Tag Archives: Bernstein

New Surgical Mesh Lawsuit Internet site Launched by Bernstein Liebhard LLP Provides Updated Information on Complications, Developing Litigation

Posted on by


New York, NY (PRWEB) June 30, 2013

A new site dedicated to delivering data to girls searching for to file surgical mesh lawsuit claims has been launched by Bernstein Liebhard LLP. Amidst other vital information, the Firms new internet site describes goods allegedly connected with mesh erosion and other transvaginal mesh complications, as well as the procedure of surgical removal and updates on lawsuits that have already been filed against transvaginal mesh makers in the U.S.

&#13

In addition to getting readily accessible to answer any queries you may possibly have about a prospective vaginal mesh lawsuit, the Firm is also providing confidential case evaluations to women who might have experienced 1 or far more of the following vaginal mesh complications: &#13

&#13

Mirena IUD Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Case Management Conference in Federal Mirena Side Effects Litigation

Posted on by


New York, New York (PRWEB) June 23, 2013

Mirena IUD lawsuit claims continue to move forward in the federal multidistrict litigation underway in U.S. District Court Southern District of New York. According to court documents, the subsequent Status Conference in the federal Mirena side effects litigation is scheduled for July 1, 2013. So far, practically 50 claims have been filed in the Southern District of New York on behalf of women who suffered spontaneous device migration, uterine perforations, and other injuries, allegedly due to the Mirena IUD. (In re: Mirena IUD Items Liability Litigation, MDL No. 2434)

&#13

We continue to hear from women who allegedly suffered significant Mirena side effects. We appear forward to additional progress in this litigation in the coming months, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and healthcare devices. The Firm continues to provide free Mirena lawsuit consultations to ladies who have been allegedly harmed as a outcome of spontaneous migration of the Mirena IUD.

&#13

Mirena Lawsuits&#13

The Mirena IUD was authorized by the U.S. Meals &amp Drug Administration (FDA) as a birth control strategy in 2000. In 2009, Mirenas authorized makes use of have been expanded to consist of therapy of heavy menstrual bleeding in females who wish to use an IUD as their approach of birth control. NewsChannel5 in Cleveland, Ohio reported on June 17th that a lot more 70,000 adverse event reports involving the Mirena IUD have been logged with the FDA because 2000, such as thousands involving device dislocation and uterine perforations.*

&#13

Court filings indicate that plaintiffs in Mirena lawsuits are alleged to have suffered severe injuries due to spontaneous migration of the IUD. Claims further allege that Bayer Healthcare Pharmaceuticals downplayed potential Mirena side effects and failed to offer adequate warnings with regards to the prospective for spontaneous device migration. In addition to the federal litigation now underway in the Southern District of New York, at least 100 Mirena IUD lawsuits have been filed in a consolidated litigation underway in New Jerseys Bergen County Superior Court. (In Re: Mirena Litigation Case No. 297)

&#13

Alleged victims of Mirena side effects might be eligible to file claims in either of these litigations if they suffered from injuries related to spontaneous migration of the IUD. Understand a lot more about Mirena lawsuits by going to Bernstein Liebhard LLPs website. For added information, please call 800-511-5092.&#13

&#13
newsnet5.com/dpp/news/local_news/investigations/thousands-of-women-complain-about-unsafe-complications-from-mirena-iud-birth-manage

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complicated person and class action lawsuits nationwide given that 1993, like those who have been harmed by unsafe drugs, defective medical devices and customer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the prime plaintiffs firms in the nation, for the previous ten consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Lawyer Marketing.

Ethicon Vaginal Mesh Lawsuits Continue, as Claims in New Jersey Litigation Exceed 3,000, Bernstein Liebhard LLP Reports

Posted on by


New York, NY (PRWEB) June 21, 2013

Vaginal mesh lawsuit filings involving Ethicon Inc.s Gynecare pelvic mesh items continue to mount in a consolidated litigation underway in New Jerseys Atlantic County Superior Court, Bernstein Liebhard LLP reports. According to the most recent Case List issued by the Court, 3,017 claims have been filed in the New Jersey Ethicon litigation on behalf of alleged victims of vaginal mesh complications. Firm partner, Jeffrey S. Grand, is serving as Co-Liaison Counsel for this litigation. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-ten).

&#13

It is not at all surprising that the vaginal mesh lawsuits filed in the New Jersey Ethicon litigation have reached this milestone. Practically two years following the FDA issued its final public overall health notification with regards to the risks linked with transvaginal mesh, we continue to hear from alleged victims of vaginal mesh complications on a standard basis, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and healthcare devices. The Firm continues to evaluate transvaginal mesh lawsuits on behalf of women allegedly injured by pelvic mesh products marketed by Ethicon, Inc. and other companies.

&#13

Vaginal Mesh Complications&#13

Concerns over complications related with transvaginal mesh devices have been mounting considering that October 2008, when the U.S. Meals and Drug Administration (FDA) alerted the public that it had received much more than 1,000 adverse occasion reports involving individuals who had received the implants to treat pelvic organ prolapse and anxiety urinary incontinence. In July 2011, the FDA issued a second alert after such reports improved by five-fold, with the regulator now warning that the frequency of complications related with transvaginal prolapse repair was not rare. According to the agency, the most frequently reported vaginal mesh complications contain mesh erosion via the vaginal epithelium, pain, urinary difficulties and infection.*

&#13

In March, the Plaintiff in the initial Ethicon mesh lawsuit to head to trial in the U.S. was awarded more than $ 11 million, like $ 7.76 million in punitive damages, after a jury in New Jersey Superior Court discovered that patients were not properly warned about the risks associated with the Gynecare Prolift device. Jeffrey S. Grand also served on the Plaintiffs trial group for this case. (Gross v. Gynecare Inc., Atl-L-6966-ten, Superior Court of Atlantic County, New Jersey)

&#13

Mr. Grand is also serving as Co-Liaison Counsel for a consolidated litigation underway in Atlantic County Superior Court for lawsuits involving pelvic mesh manufactured by C.R. Bard Inc. (In re: Pelvic Mesh Litigation/Bard, No. L-6339-ten), and is a member of the Plaintiffs Steering Committees in four federal transvaginal mesh multi-district litigations underway in U.S. District Court, Southern District of West Virginia. These proceedings incorporate: In re: Boston Scientific Corp., Pelvic Repair Systems Goods Liability Litigation (MDL No. 2326) In re: C.R. Bard, Inc., In Re: American Healthcare Systems, Inc., Pelvic Repair Systems Products Liability Litigation (MDL No. 2325) In re: C.R. Bard, Inc., Pelvic Repair Systems Items Liability Litigation (MDL No. 2187) and In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation (MDL No. 2327). The 1st trial in that litigation, involving a C.R. Bard vaginal mesh lawsuit, is scheduled to begin on July 8, 2013.

&#13

Alleged victims of vaginal mesh injuries might be eligible to seek compensation for health-related costs, discomfort and suffering and other damages. Learn a lot more about how to file a vaginal mesh lawsuit by going to Bernstein Liebhard’s internet site, or by contacting one particular of the Firms attorneys straight at 800-511-5092.

&#13

*fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/UroGynSurgicalMesh/default.htm

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide given that 1993, including those who have been harmed by dangerous drugs, defective medical devices and customer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the prime plaintiffs firms in the nation, for the past ten consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

(800) 511-5092

&#13

Attorney Advertising.

Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Mounting Reports of Mirena Side Effects, Like Device Migration, Uterine Perforations

Posted on by


New York, New York (PRWEB) June 18, 2013

As Mirena lawsuit claims continue to move forward in each state and federal court, a new report has revealed that that the IUD has been the subject of far more than 70,000 U.S. Meals &amp Drug Administration (FDA) adverse occasion reports since coming on the market in 2000. According to NewsChannel5 in Cleveland, Ohio, over 4.700 Mirena customers have reported device dislocation or migration to the FDA given that 2008, even though far more than 1,300 have reportedly seasoned uterine perforations due to Mirena.*

&#13

We are not at all shocked by these numbers, as our Firm receives inquiries on a standard basis from females who have allegedly suffered uterine perforations, device migration, and other severe Mirena side effects. The injuries described in this report echo a lot of what we have heard from our own Mirena lawsuit consumers, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to provide free Mirena IUD lawsuit consultations to females who were allegedly harmed by this contraceptive device.

&#13

Mirena Lawsuits&#13

According to the NewsChannel5 report, dozens of Mirena IUD lawsuits are at the moment pending in courts around the nation. Plaintiffs in these claims have allegedly suffered horrific injuries due to dislocation of the Mirena IUD, which includes instances where the device punctured the uterus and moved into the abdominal cavity and broken other organs. In one case, a plaintiff allegedly suffered a lacerated liver due to Mirena migration, while other people had been forced to undergo hysterectomies due to the fact of their injuries. 1 lady interviewed for the report even suffered permanent nerve damage right after undergoing surgery to take away a Mirena IUD that had migrated outside of her uterus. Regardless of these types of incidents, nevertheless, there is no indication that Bayer is organizing to concern a Mirena recall for the IUD.

&#13

Court documents indicate that some 100 MIrena lawsuits are pending in a consolidated litigation underway in New Jersey Superior Court, Bergen County. A Case Management Conference has been scheduled for July 1st in that litigation. (In Re: Mirena Litigation Case No. 297) Meanwhile, at least 50 federally-filed Mirena side impact claims are also pending in a federal multidistrict litigation now underway in U.S. District Court, Southern District of New York. Even so, attorneys interviewed for the NewsChannel5 report predicted that hundreds of added Mirena IUD lawsuits would likely be filed in the near future. (In re: Mirena IUD Merchandise Liability Litigation, MDL No. 2434)

&#13

Girls who suffered device migration, uterine perforations and other serious Mirena side effects could be entitled to compensation for their health-related costs, lost wages, pain and suffering and other damages. To understand much more about filing a Mirena lawsuit, please pay a visit to Bernstein Liebhard LLPs internet site. For far more data, please call 800-511-5092.

&#13

*newsnet5.com/dpp/news/neighborhood_news/investigations/thousands-of-ladies-complain-about-harmful-complications-from-mirena-iud-birth-manage

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide because 1993, such as those who have been harmed by unsafe drugs, defective healthcare devices and consumer merchandise. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the nation, for the previous 10 consecutive years.

&#13

Bernstein Liebhard LLP &#13

ten East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Lawyer Marketing.

Bernstein Liebhard LLP Investigating Diabetes Drug Lawsuits Involving Byetta, Januvia, Victoza and Similar Medications

Posted on by


New York, New York (PRWEB) June 16, 2013

The nationwide law firm of Bernstein Liebhard LLP is investigating diabetes drug lawsuits on behalf of individuals treated with Byetta, Januvia, Victoza and other medications recognized as incretin mimetics, and who have been diagnosed with pancreatitis, pancreatic cancer or thyroid cancer. Type II diabetics who had been treated with an incretin mimetic and who have been diagnosed with a single of these illnesses may be entitled to compensation for health-related bills, lost wages, discomfort and suffering and other damages. Medicines integrated in the Firms diabetes drug lawsuit investigation incorporate:&#13

&#13

Biomet Hip Lawsuits Mount in Federal Biomet M2a Magnum Hip Replacement Litigation, Bernstein Liebhard LLP Reports

Posted on by


New York, New York (PRWEB) June 16, 2013

Biomet hip lawsuit claims alleging severe injuries due to the Biomet M2a Magnum Hip Replacement Technique continue to mount in a federal multidistrict litigation underway in U.S. District Court, Northern District of Indiana, Bernstein Liebhard LLP reports. According to an MDL Statistics Report issued on May possibly 14th by the U.S. Judicial Panel on Multidistrict Litigation (JPML), at least 308 Biomet hip replacement claims have been filed in the federal litigation given that it was established in October 2012. (In re: Biomet M2a Magnum Hip Implant Goods Liability Litigation MDL No. 2391)

&#13

We continue to hear from people fitted with metal-on-metal hip implants, including the Biomet M2a Magnum, who allegedly suffered significant complications linked with the failure of their device. It is not surprising that the number of Biomet hip replacement lawsuits filed in this litigation has currently surpassed 300, says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and healthcare devices. The Firm is actively filing Biomet hip lawsuits in the federal multidistrict litigation, and continues to supply totally free and confidential case evaluations to men and women who might have been injured by Biomet M2a Magnum implants.

&#13

Biomet Hip Replacement Lawsuits&#13

According to court documents, Biomet hip lawsuits allege the metal-on-metal style of the Biomet M2a Magnum implant is prone to put on, and can create higher metal ion levels. This could trigger sufferers to endure metallosis and other adverse tissue reactions, premature device failure and other complications that necessitate revision surgery to get rid of and replace the device. When the multidistrict litigation was established by the JPML in October 2011, 66 Biomet hip replacement claims had been pending in federal courts all through the U.S.

&#13

The U.S. Food &amp Drug Administration (FDA) has been investigating metal-on-metal hip implants because February 2011, amid concerns that metal ions shed from the hips can outcome in metallosis, adverse neighborhood tissue reactions, and early failure. In January, the agency issued new guidance for hip replacement patients fitted with these devices that suggested metal ion testing in those experiencing symptoms of hip implant failure. The FDA also mentioned it had proposed a new rule that would make all-metal hips ineligible for 510(k) approvals, a process which permitted metal-on-metal hips to come to market without having very first undergoing human clinical trials.*

&#13

Biomet M2a Magnum hip recipients who allegedly suffered injuries as a result of the device might be entitled to compensation for their healthcare expenses, lost wages and discomfort and suffering. To understand a lot more about the litigation surrounding this and other metal-on-metal hip implants, please visit Bernstein Liebhard LLPs site, or get in touch with 1 our attorneys today at 800-511-5092.

&#13

*fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide because 1993, such as those who have been harmed by hazardous drugs, defective healthcare devices and consumer goods. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the best plaintiffs firms in the nation, for the past 10 consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Lawyer Marketing.

Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Study Investigating Robot-Assisted Kidney Removal

Posted on by


New York, NY (PRWEB) June 06, 2013

As da Vinci robotic surgery lawsuit claims mount in courts around the nation, Bernstein Liebhard LLP notes that a new study has reported that the price of robot-assisted partial nephrectomy (kidney removal) procedures has enhanced far more than 45 percent because 2010. Even though the research, which was presented on Could 7th at the annual meeting of the American Urological Association, discovered that individuals undergoing robot-assisted surgery typically did well, the study also reported much more “excessive” hospital charges related with the robotic process.*

&#13

We continue to hear from da Vinci surgery patients who have allegedly suffered serious complications due to bad robotic surgery. While the study noted that sufferers undergoing robotic partial nephrectomies typically did effectively, its findings with regards to excessive hospital charges are a reminder that the risks, benefits and charges linked with robot surgery need further evaluation, says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and healthcare devices. The Firm is currently evaluating da Vinci surgery robot lawsuits on behalf of alleged victims of negative robotic surgery.

&#13

Da Vinci Surgery Robot Lawsuits&#13

According to court documents, the da Vinci Surgical Technique has been named in a increasing number of bad robotic surgery lawsuits. In an Apri 19th regulatory filing, Intuitive Surgical Inc., the manufacture of the robot, disclosed it had been served with at least 26 such claims, all of which allege injuries due to defects in the da Vinci robot, and/or inadequate coaching of surgeons. The nations very first trial of a Vinci surgery robot lawsuit concluded final month in Washington State Court, with a victory for Intuitive Surgical. Nevertheless, Bloomberg.com reported on May possibly 23rd that an lawyer representing the plaintiffs predicted numerous much more filings, and maintained that that several of these claims would have more favorable outcomes for alleged victims of undesirable robotic surgery.** (Estate of Fred E. Taylor v. Intuitive Surgical, 09-two-03136-5, Superior Court, State of Washington, Kitsap County)

&#13

Whilst the study presented last month at the American Association of Urology meeting reported good outcomes in robotic surgery individuals, an boost in adverse event reports connected to the da Vinci robot has caught the consideration of federal overall health regulators. According to a Bloomberg.com report published on February 28th, the da Vinci robot has been connected with 70 deaths in adverse occasion reports made to the U.S. Food &amp Drug Administration (FDA) given that 2009. Reports of poor robotic surgery complications have also improved, jumping to at least 115 in 2012 from 24 in 2009. In January the agency started to survey doctors who use the machine in order to aid it figure out if the increase is due to a difficulty with the da Vinci technology.***

&#13

In the previous, other research have raised queries about the fees and advantages of robotic surgery. For example, a study published in the Journal of the American Medical Association in February reported that the fees for a da Vinci hysterectomy was far more costly compared to other methods, with tiny difference in complication rates.*****

&#13

Alleged victims of negative robotic surgery related with the da Vinci robot might be eligible to file a individual injury lawsuit to receive compensation for medical expenditures, lost wages, discomfort and suffering, and far more. A wealth of data with regards to da Vinci surgery robot lawsuits is offered at Bernstein Liebhard LLPs website. For additional details, please call 800-511-5092.

&#13

*http://www.news-medical.net/news/20130508/Robotic-partial-nephrectomy-entails-excessive-hospital-charges.aspx news-medical.net, May possibly 8, 2013&#13

**sec.gov/Archives/edgar/data/1035267/000119312513162385/d508282d10q.htm Intuitive Surgical SEC Filing, April 19, 2013&#13

***bloomberg.com/news/2013-05-23/intuitive-wins-trial-defeats-negligent-education-claims.html Bloomberg.com, May possibly 23, 2013&#13

****bloomberg.com/news/2013-02-28/intuitive-surgical-robots-probed-by-u-s-in-survey-of-surgeons.html Bloomberg.co, February 28, 2013&#13

*****jama.jamanetwork.com/post.aspx?articleid=1653522 JAMA, February 20, 2013

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide given that 1993, including these who have been harmed by unsafe drugs, defective healthcare devices and consumer merchandise. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the leading plaintiffs firms in the country, for the past 10 consecutive years.

&#13

Bernstein Liebhard LLP &#13

ten East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Lawyer Marketing.

Actos Lawsuits: Bernstein Liebhard LLP Notes Far more Than 1,500 Situations Now Filed in Federal Litigation

Posted on by


New York, New York (PRWEB) June 02, 2013

Court documents indicate that more than 1,500 Actos lawsuit claims alleging bladder cancer are now pending in a federal litigation underway in the U.S. District Court, Western District of Louisiana, Bernstein Liebhard LLP reports.

&#13

According to court records, an update on the number of Actos filings in the federal litigation was presented at a May 23rd status conference, which also addressed troubles associated to the status of discovery and the scheduling of bellwether trials in the litigation. Lawsuits filed in this proceeding allege the possible for long-term use of Actos, a type two diabetes drug manufactured by Takeda Pharmaceuticals, to trigger or worsen bladder cancer. (In re: Actos Solution Liability Litigation, MDL No. 2299)

&#13

As we continue to receive inquiries about prospective Actos lawsuits from individuals who allege extended-term use of the drug triggered their bladder cancer, we are pleased to see this litigation moving forward, says Bernstein Liebhard LLP, nationwide law firm representing the victims of defective drugs and health-related devices. The Firm is at the moment offering free Actos bladder cancer lawsuit evaluations to individuals who developed bladder cancer right after utilizing the medication for an extended period of time.

&#13

Actos Bladder Cancer Lawsuit Allegations

&#13

The federal multidistrict litigation for Actos bladder cancer lawsuits was produced in the U.S. District Court, Western District of Louisiana in December 2011, after the U.S. Meals and Drug Administration issued an alert warning the public that long-term use of the medication might increase a individuals threat for establishing bladder cancer.* There are now 1,500 instances pending in in the Western District of Louisiana, exactly where the proceeding continues to move forward. According to court documents, the next status conference in the litigation has been scheduled for June 20, 2013. Court records further indicate the first bellwether trials for the Actos bladder cancer litigation have been scheduled as effectively, with the initial trial is slated to begin on January 27, 2014, with the second to adhere to on April 14, 2014.

&#13

In addition to the federal litigation, Bloomberg.com reported on May 1st that claims filed more than the medication employed to manage blood-sugar levels in type 2 diabetes sufferers are pending in state litigations in Illinois and California.**

&#13

Individuals who took Actos and developed bladder cancer following lengthy-term use of the drug may possibly be eligible to seek compensation for medical bills, lost wages, pain and suffering and other damages. Understand more about how to file an Actos lawsuit by going to Bernstein Liebhard LLPs web site or by calling a single of the Firms Actos lawyers at 800-511-5092.

&#13

*FDA, June 15, 2011 fda.gov/drugs/drugsafety/ucm259150.htm&#13

**bloomberg.com/news/2013-05-01/takeda-gets-six-five-million-diabetes-drug-verdict-thrown-out.html

&#13

About Bernstein Liebhard LLP

&#13

Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, which includes these who have been harmed by harmful drugs, defective health-related devices and customer goods. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the nation, for the previous ten consecutive years.

&#13

Bernstein Liebhard LLP&#13

10 East 40th Street&#13

New York, New York 10016&#13

800-511-5092

&#13

Attorney Advertising.

Vaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Pretrial Order in Federal Transvaginal Mesh Litigation

Posted on by


New York, New York (PRWEB) May possibly 30, 2013

Thousands of vaginal mesh lawsuit claims continue to move forward in federal litigations now underway in U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports. According to a Pretrial Order issued by the Court on May possibly 29th, parties in the litigations have reached an agreement regarding the delayed filing of claims and the application of the statute of limitations. According to the Order, the agreement will apply to 4 litigations underway in the Southern District of West Virginia: American Health-related Systems, Inc., Pelvic Repair Systems Items Liability Litigation (MDL No. 2325) In re: Boston Scientific Corp., Pelvic Repair Systems Items Liability Litigation (MDL No. 2326) In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation (MDL No. 2187) and In re: Ethicon, Inc., Pelvic Repair Systems Goods Liability Litigation ( MDL No. 2327). Bernstein Liebhard LLP partner, Jeffrey S. Grand, serves on the Plaintiffs Steering Committee in all of these proceedings.

&#13

This Order will make certain that vaginal mesh lawsuits are filed in an effective manner in these 4 proceedings. We are pleased to see these situations progressing, as we continue to hear from ladies who allegedly suffered significant vaginal mesh complications following surgery to treat pelvic organ prolapse and pressure urinary incontinence, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and health-related devices. The Firm is at present representing hundreds of girls in state and federal courts who allegedly suffered mesh erosion, pain, scarring, infection and other serious vaginal mesh complications.

&#13

Vaginal Mesh Complications&#13

Pelvic mesh devices employed to treat pelvic organ prolapse and pressure urinary incontinence have been the topic of a U.S. Meals &amp Drug Administration (FDA) security assessment because October 2008, when the agency warned that it had received more than 1,000 vaginal mesh complication reports for the duration of a 3-year period. In July 2011, the FDA changed its stance on the frequency of injuries associated with prolapse repair, stating it no longer regarded these complications to be rare. At that time, the agency revealed it had received far more than two,800 reports of vaginal mesh injuries because its 2008 communication.*

&#13

Court documents indicate that thousands of women have given that filed transvaginal mesh lawsuits, all of which allege the manufacturers of the devices have been negligent in designing the items, and failed to warn customers of their significant risks. Thousands of added transvaginal mesh claims involving goods marketed by Ethicon Inc. and C.R. Bard have been consolidated in New Jersey Superior Court, Atlantic County, exactly where Bernstein Liebhard LLP partner, Jeffrey, S.. Grand is serving as Co-Liaison Counsel. (In re: Pelvic Mesh Litigation/Bard, No. L-6339-ten, and In re: Pelvic Mesh/Gynecare Litigation, No. 6341-ten) He also served on the trial team in the litigations initial Ethicon mesh trial, which concluded with an award of far more than $ 11 million, including punitive damages, to the Plaintiff. (Gross v. Gynecare Inc., Atl-L-6966-ten, Superior Court of Atlantic County, New Jersey).

&#13

Victims of alleged vaginal mesh complications could be entitled to compensation for their healthcare bills, discomfort and suffering, and other injuries. A wealth of info relating to transvaginal mesh lawsuits can be located at Bernstein Liebhard’s web site. To learn a lot more, please get in touch with 800-511-5092.

&#13

*fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/UroGynSurgicalMesh/default.htm

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide since 1993, which includes these who have been harmed by unsafe drugs, defective health-related devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the nation, for the past ten consecutive years.

&#13

Bernstein Liebhard LLP &#13

ten East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Lawyer Marketing.

Biomet Hip Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Case Management Conference in Federal Biomet Hip Replacement Litigation

Posted on by


New York, New York (PRWEB) May 26, 2013

The federal litigation established for Biomet hip lawsuits continues to move forward in U.S. District Court, Northern District of Indiana, Bernstein Liebhard LLP reports. According to the Courts website, the litigations next Case Management Conference has been scheduled for June 17th. All of the lawsuits pending in the Biomet hip replacement litigation allege the metal-on-metal design of the Biomet M2a Magnum hip can generate high levels of metal ions, leading to metallosis in the surrounding tissue and early failure of the device. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation MDL No. 2391)

Our Firm is already representing clients in the federal Biomet hip replacement litigation, and continues to receive inquiries from Biomet M2a hip recipients who have allegedly suffered serious and debilitating complications related to the metal-on-metal device. We are pleased to see this proceeding moving forward, says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free Biomet hip lawsuit evaluations to individuals allegedly injured by the Biomet M2a hip.

Biomet Hip Lawsuits

Biomet M2a Magnum Hip Replacements are metal-on-metal hip implants, which consist of a ball and cup made from a chromium-cobalt alloy. As of March 2013, court documents indicated that more than 140 Biomet hip lawsuits were pending in the federal Biomet hip replacement litigation. All federally-filed Biomet hip lawsuits were ordered transferred to the Northern District of Indiana in October 2012, in anticipation of a large number of claims.

This past January, the U.S. Food & Drug Administration (FDA) warned that metal debris shed as metal-on-metal hip components wear may accumulate to dangerous levels in the body. This occurrence can result in bone and/or soft tissue damage in the area surrounding the implant and joint, leading to adverse local tissue reactions, premature device failure, and even additional symptoms or illnesses elsewhere in the body. Among other things, the FDA cautioned doctors to consider metal ion testing if patients are experiencing symptoms of hip implant failure. According to the January announcement, the FDA is considering implementing new regulations for metal-on-metal hip implants that would make the devices ineligible for 510(k) clearances, which allowed such implants to come to market without human clinical trials.*

Alleged victims of Biomet hip replacement problems, including metallosis, hip implant failure, and other serious complications may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. A wealth of information about Biomet hip lawsuits is available at Bernstein Liebhards website. For additional information, please contact one of our attorneys today by calling 800-511-5092.

*fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

800-511-5092

ATTORNEY ADVERTISING.